Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.

Levy-Shraga Y, Lerner-Geva L, Modan-Moses D, Graph-Barel C, Mazor-Aronovitch K, Boyko V, Pinhas-Hamiel O.

Exp Clin Endocrinol Diabetes. 2013 Apr;121(4):225-9. doi: 10.1055/s-0032-1331698. Epub 2013 Jan 17.

PMID:
23329580
2.

[Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump)].

Pańkowska E, Lipka M, Wysocka M, Szypowska A, Trippenbach-Dulska H, Czaplińska M, Kołodziejska B.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(1):11-5. Polish.

PMID:
12831632
3.

Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.

Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV.

Pediatrics. 2004 Dec;114(6):1601-5. Erratum in: Pediatrics. 2005 Feb;115(2):518.

PMID:
15574621
4.
5.

Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Shalitin S, Lahav-Ritte T, Lebenthal Y, Devries L, Phillip M.

Diabetes Technol Ther. 2012 May;14(5):389-97. doi: 10.1089/dia.2011.0267. Epub 2012 Jan 27.

PMID:
22283639
6.
7.
8.

[Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].

Minkina-Pedras M, Jarosz-Chobot P, Małecka-Tendera E, Deja G.

Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(3):171-6. Polish.

PMID:
16232370
9.

Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years.

Jakisch BI, Wagner VM, Heidtmann B, Lepler R, Holterhus PM, Kapellen TM, Vogel C, Rosenbauer J, Holl RW; German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy.

Diabet Med. 2008 Jan;25(1):80-5. doi: 10.1111/j.1464-5491.2007.02311.x.

PMID:
18199134
11.
12.

Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment?

Sulmont V, Souchon PF, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M.

J Pediatr. 2010 Jul;157(1):103-7. doi: 10.1016/j.jpeds.2009.12.034. Epub 2010 Mar 15.

PMID:
20227730
13.

Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.

Brorsson AL, Viklund G, Örtqvist E, Lindholm Olinder A.

Pediatr Diabetes. 2015 Nov;16(7):546-53. doi: 10.1111/pedi.12209. Epub 2014 Oct 20.

PMID:
25327782
14.
15.

[Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].

Hasselmann C, Bonnemaison E, Faure N, Mercat I, Bouillo Pépin-Donat M, Magontier N, Chantepie A, Labarthe F.

Arch Pediatr. 2012 Jun;19(6):593-8. doi: 10.1016/j.arcped.2012.03.051. Epub 2012 May 14. French.

PMID:
22584198
16.
17.
18.

Sustained benefits of continuous subcutaneous insulin infusion.

Hughes CR, McDowell N, Cody D, Costigan C.

Arch Dis Child. 2012 Mar;97(3):245-7. doi: 10.1136/adc.2010.186080. Epub 2010 Nov 24.

PMID:
21109506
19.

A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes.

Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE.

Diabetes Care. 2005 Jan;28(1):15-9.

PMID:
15616227
20.

Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.

Fendler W, Baranowska AI, Mianowska B, Szadkowska A, Mlynarski W.

Acta Diabetol. 2012 Oct;49(5):363-70. doi: 10.1007/s00592-011-0332-7. Epub 2011 Oct 1.

Supplemental Content

Support Center